Crossmark

On the prevalence of smooth polymorphs at the nanoscale: implications for pharmaceuticals

Crossref DOI link: https://doi.org/10.1039/C8CE02098A

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Belenguer, Ana M. https://orcid.org/0000-0002-0443-4856
Cruz-Cabeza, Aurora J. https://orcid.org/0000-0002-0957-4823
Lampronti, Giulio I. https://orcid.org/0000-0002-1430-3446
Sanders, Jeremy K. M. https://orcid.org/0000-0002-5143-5210
Funding

Funding for this research was provided by:

Royal Society
License Information

Accepted Manuscript valid from 2020-02-14
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Ana M. Belenguer (ORCID)

: Aurora J. Cruz-Cabeza (ORCID)

: Aurora J. Cruz-Cabeza (ResearcherID)

: Giulio I. Lampronti (ORCID)

: Jeremy K. M. Sanders (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 12 December 2018; Accepted 14 February 2019; Accepted Manuscript published 14 February 2019; Advance Article published 21 February 2019; Version of Record published 25 March 2019